| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA photolyase activity | 4.97e-06 | 2 | 45 | 2 | GO:0003913 | |
| GeneOntologyMolecularFunction | DNA (6-4) photolyase activity | 4.97e-06 | 2 | 45 | 2 | GO:0003914 | |
| GeneOntologyMolecularFunction | deoxyribodipyrimidine photo-lyase activity | 4.97e-06 | 2 | 45 | 2 | GO:0003904 | |
| GeneOntologyMolecularFunction | blue light photoreceptor activity | 4.97e-06 | 2 | 45 | 2 | GO:0009882 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.56e-05 | 262 | 45 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 7.88e-05 | 37 | 45 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.63e-04 | 230 | 45 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 4.13e-04 | 614 | 45 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 5.54e-04 | 645 | 45 | 7 | GO:0140640 | |
| GeneOntologyMolecularFunction | photoreceptor activity | 6.61e-04 | 17 | 45 | 2 | GO:0009881 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 1.56e-03 | 26 | 45 | 2 | GO:0052742 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.38e-03 | 118 | 45 | 3 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.93e-03 | 127 | 45 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 3.03e-03 | 441 | 45 | 5 | GO:0016887 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 3.32e-03 | 38 | 45 | 2 | GO:0000146 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 3.85e-03 | 41 | 45 | 2 | GO:0001727 | |
| GeneOntologyMolecularFunction | FAD binding | 4.42e-03 | 44 | 45 | 2 | GO:0071949 | |
| GeneOntologyBiologicalProcess | blue light signaling pathway | 4.87e-06 | 2 | 46 | 2 | GO:0009785 | |
| GeneOntologyBiologicalProcess | cellular response to blue light | 4.87e-06 | 2 | 46 | 2 | GO:0071483 | |
| GeneOntologyBiologicalProcess | negative regulation of circadian rhythm | 5.70e-06 | 16 | 46 | 3 | GO:0042754 | |
| GeneOntologyBiologicalProcess | maintenance of location | 2.56e-05 | 396 | 46 | 7 | GO:0051235 | |
| GeneOntologyBiologicalProcess | negative regulation of corticosteroid hormone secretion | 4.85e-05 | 5 | 46 | 2 | GO:2000847 | |
| GeneOntologyBiologicalProcess | negative regulation of steroid hormone secretion | 4.85e-05 | 5 | 46 | 2 | GO:2000832 | |
| GeneOntologyBiologicalProcess | negative regulation of glucocorticoid secretion | 4.85e-05 | 5 | 46 | 2 | GO:2000850 | |
| GeneOntologyBiologicalProcess | secretion | CRY2 MYO1G CHD7 DRD2 WDR41 ACACB MYO5A PIK3C2A ADCY8 SEC24A CRY1 | 5.85e-05 | 1221 | 46 | 11 | GO:0046903 |
| GeneOntologyBiologicalProcess | response to blue light | 7.26e-05 | 6 | 46 | 2 | GO:0009637 | |
| GeneOntologyBiologicalProcess | negative regulation of glucocorticoid receptor signaling pathway | 7.26e-05 | 6 | 46 | 2 | GO:2000323 | |
| GeneOntologyBiologicalProcess | secretion by cell | 9.53e-05 | 1064 | 46 | 10 | GO:0032940 | |
| GeneOntologyBiologicalProcess | negative regulation of dopamine secretion | 1.01e-04 | 7 | 46 | 2 | GO:0033602 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion by cell | 1.11e-04 | 214 | 46 | 5 | GO:1903531 | |
| GeneOntologyBiologicalProcess | regulation of lipid localization | 1.14e-04 | 215 | 46 | 5 | GO:1905952 | |
| GeneOntologyBiologicalProcess | export from cell | 1.85e-04 | 1153 | 46 | 10 | GO:0140352 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion | 1.86e-04 | 239 | 46 | 5 | GO:0051048 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | 2.06e-04 | 740 | 46 | 8 | GO:1903530 | |
| GeneOntologyBiologicalProcess | lipid localization | 2.36e-04 | 565 | 46 | 7 | GO:0010876 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid transport | 2.65e-04 | 56 | 46 | 3 | GO:0032369 | |
| GeneOntologyBiologicalProcess | negative regulation of transport | 2.98e-04 | 587 | 46 | 7 | GO:0051051 | |
| GeneOntologyBiologicalProcess | regulation of glucocorticoid receptor signaling pathway | 3.17e-04 | 12 | 46 | 2 | GO:2000322 | |
| GeneOntologyBiologicalProcess | hormone secretion | 3.23e-04 | 420 | 46 | 6 | GO:0046879 | |
| GeneOntologyBiologicalProcess | regulation of secretion | 3.52e-04 | 801 | 46 | 8 | GO:0051046 | |
| GeneOntologyBiologicalProcess | response to inactivity | 3.74e-04 | 13 | 46 | 2 | GO:0014854 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission, glutamatergic | 3.74e-04 | 13 | 46 | 2 | GO:0051967 | |
| GeneOntologyBiologicalProcess | hormone transport | 3.76e-04 | 432 | 46 | 6 | GO:0009914 | |
| GeneOntologyBiologicalProcess | regulation of glucocorticoid secretion | 4.35e-04 | 14 | 46 | 2 | GO:2000849 | |
| GeneOntologyBiologicalProcess | response to morphine | 5.02e-04 | 15 | 46 | 2 | GO:0043278 | |
| GeneOntologyBiologicalProcess | glucocorticoid secretion | 5.72e-04 | 16 | 46 | 2 | GO:0035933 | |
| GeneOntologyBiologicalProcess | response to isoquinoline alkaloid | 5.72e-04 | 16 | 46 | 2 | GO:0014072 | |
| GeneOntologyBiologicalProcess | circadian regulation of gene expression | 6.26e-04 | 75 | 46 | 3 | GO:0032922 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated glucocorticoid signaling pathway | 6.48e-04 | 17 | 46 | 2 | GO:0042921 | |
| GeneOntologyBiologicalProcess | locomotion involved in locomotory behavior | 6.48e-04 | 17 | 46 | 2 | GO:0031987 | |
| GeneOntologyBiologicalProcess | regulation of lipid transport | 6.73e-04 | 179 | 46 | 4 | GO:0032368 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid localization | 7.02e-04 | 78 | 46 | 3 | GO:1905953 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated corticosteroid signaling pathway | 7.28e-04 | 18 | 46 | 2 | GO:0031958 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 7.56e-04 | 80 | 46 | 3 | GO:0050805 | |
| GeneOntologyBiologicalProcess | regulation of growth hormone secretion | 8.12e-04 | 19 | 46 | 2 | GO:0060123 | |
| GeneOntologyBiologicalProcess | lipid transport | 8.62e-04 | 506 | 46 | 6 | GO:0006869 | |
| GeneOntologyBiologicalProcess | prepulse inhibition | 9.01e-04 | 20 | 46 | 2 | GO:0060134 | |
| GeneOntologyBiologicalProcess | regulation of corticosteroid hormone secretion | 9.95e-04 | 21 | 46 | 2 | GO:2000846 | |
| GeneOntologyBiologicalProcess | growth hormone secretion | 1.09e-03 | 22 | 46 | 2 | GO:0030252 | |
| GeneOntologyBiologicalProcess | response to peptide hormone | 1.10e-03 | 530 | 46 | 6 | GO:0043434 | |
| GeneOntologyBiologicalProcess | regulation of hormone secretion | 1.13e-03 | 355 | 46 | 5 | GO:0046883 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 1.17e-03 | 358 | 46 | 5 | GO:0015850 | |
| GeneOntologyBiologicalProcess | negative regulation of catecholamine secretion | 1.19e-03 | 23 | 46 | 2 | GO:0033604 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 1.30e-03 | 24 | 46 | 2 | GO:0048015 | |
| GeneOntologyBiologicalProcess | corticosteroid hormone secretion | 1.30e-03 | 24 | 46 | 2 | GO:0035930 | |
| GeneOntologyBiologicalProcess | response to glucagon | 1.41e-03 | 25 | 46 | 2 | GO:0033762 | |
| GeneOntologyBiologicalProcess | entrainment of circadian clock by photoperiod | 1.41e-03 | 25 | 46 | 2 | GO:0043153 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating adrenergic receptor signaling pathway | 1.41e-03 | 25 | 46 | 2 | GO:0071880 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic cation transmembrane transport | 1.52e-03 | 380 | 46 | 5 | GO:1904062 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | 1.53e-03 | 1249 | 46 | 9 | GO:0048878 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone secretion | 1.57e-03 | 103 | 46 | 3 | GO:0046888 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | 1.60e-03 | 571 | 46 | 6 | GO:0043410 | |
| GeneOntologyBiologicalProcess | lipid storage | 1.66e-03 | 105 | 46 | 3 | GO:0019915 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | 1.74e-03 | 1272 | 46 | 9 | GO:1901698 | |
| MousePheno | abnormal periosteum morphology | 1.93e-05 | 3 | 36 | 2 | MP:0010971 | |
| Domain | DNA_photolyase | 5.68e-06 | 2 | 45 | 2 | PF00875 | |
| Domain | DNA_photolyase_N | 5.68e-06 | 2 | 45 | 2 | IPR006050 | |
| Domain | FAD_binding_7 | 5.68e-06 | 2 | 45 | 2 | PF03441 | |
| Domain | Cryptochr/Photolyase_FAD-bd | 5.68e-06 | 2 | 45 | 2 | IPR005101 | |
| Domain | PHR_CRY_ALPHA_BETA | 5.68e-06 | 2 | 45 | 2 | PS51645 | |
| Domain | SNF2_N | 6.17e-05 | 32 | 45 | 3 | IPR000330 | |
| Domain | SNF2_N | 6.17e-05 | 32 | 45 | 3 | PF00176 | |
| Domain | BRK | 8.46e-05 | 6 | 45 | 2 | SM00592 | |
| Domain | BRK_domain | 8.46e-05 | 6 | 45 | 2 | IPR006576 | |
| Domain | BRK | 8.46e-05 | 6 | 45 | 2 | PF07533 | |
| Domain | PI3Ka | 2.02e-04 | 9 | 45 | 2 | PF00613 | |
| Domain | - | 2.02e-04 | 9 | 45 | 2 | 1.25.40.70 | |
| Domain | PI3Ka | 2.02e-04 | 9 | 45 | 2 | SM00145 | |
| Domain | PIK_HELICAL | 2.52e-04 | 10 | 45 | 2 | PS51545 | |
| Domain | PI_Kinase | 2.52e-04 | 10 | 45 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 2.52e-04 | 10 | 45 | 2 | IPR001263 | |
| Domain | TIL | 3.69e-04 | 12 | 45 | 2 | PF01826 | |
| Domain | C8 | 3.69e-04 | 12 | 45 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 4.35e-04 | 13 | 45 | 2 | IPR014853 | |
| Domain | C8 | 4.35e-04 | 13 | 45 | 2 | SM00832 | |
| Domain | TIL_dom | 5.07e-04 | 14 | 45 | 2 | IPR002919 | |
| Domain | PI3/4_kinase_CS | 5.84e-04 | 15 | 45 | 2 | IPR018936 | |
| Domain | VWD | 6.67e-04 | 16 | 45 | 2 | SM00216 | |
| Domain | VWF_type-D | 6.67e-04 | 16 | 45 | 2 | IPR001846 | |
| Domain | - | 6.67e-04 | 16 | 45 | 2 | 1.10.1070.11 | |
| Domain | VWFD | 6.67e-04 | 16 | 45 | 2 | PS51233 | |
| Domain | PI3Kc | 6.67e-04 | 16 | 45 | 2 | SM00146 | |
| Domain | VWD | 6.67e-04 | 16 | 45 | 2 | PF00094 | |
| Domain | P-loop_NTPase | 8.45e-04 | 848 | 45 | 8 | IPR027417 | |
| Domain | PI3/4_kinase_cat_dom | 8.47e-04 | 18 | 45 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 8.47e-04 | 18 | 45 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 8.47e-04 | 18 | 45 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 8.47e-04 | 18 | 45 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 8.47e-04 | 18 | 45 | 2 | PS00916 | |
| Domain | VWC_out | 9.46e-04 | 19 | 45 | 2 | SM00215 | |
| Domain | IQ | 9.78e-04 | 81 | 45 | 3 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.33e-03 | 90 | 45 | 3 | IPR000048 | |
| Domain | IQ | 1.46e-03 | 93 | 45 | 3 | PS50096 | |
| Domain | Chromo_domain | 1.51e-03 | 24 | 45 | 2 | IPR023780 | |
| Domain | Chromo | 1.78e-03 | 26 | 45 | 2 | PF00385 | |
| Domain | CHROMO_1 | 2.06e-03 | 28 | 45 | 2 | PS00598 | |
| Domain | CHROMO_2 | 2.06e-03 | 28 | 45 | 2 | PS50013 | |
| Domain | Helicase_C | 2.18e-03 | 107 | 45 | 3 | PF00271 | |
| Domain | HELICc | 2.18e-03 | 107 | 45 | 3 | SM00490 | |
| Domain | Helicase_C | 2.24e-03 | 108 | 45 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 2.30e-03 | 109 | 45 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.30e-03 | 109 | 45 | 3 | PS51192 | |
| Domain | DEXDc | 2.30e-03 | 109 | 45 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.36e-03 | 110 | 45 | 3 | IPR014001 | |
| Domain | Chromodomain-like | 2.69e-03 | 32 | 45 | 2 | IPR016197 | |
| Domain | Chromo/shadow_dom | 2.86e-03 | 33 | 45 | 2 | IPR000953 | |
| Domain | CHROMO | 2.86e-03 | 33 | 45 | 2 | SM00298 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.21e-03 | 35 | 45 | 2 | IPR002464 | |
| Domain | VWFC_1 | 3.39e-03 | 36 | 45 | 2 | PS01208 | |
| Domain | VWC | 3.78e-03 | 38 | 45 | 2 | SM00214 | |
| Domain | DEAH_ATP_HELICASE | 3.78e-03 | 38 | 45 | 2 | PS00690 | |
| Domain | Myosin_head_motor_dom | 3.78e-03 | 38 | 45 | 2 | IPR001609 | |
| Domain | VWFC_2 | 3.78e-03 | 38 | 45 | 2 | PS50184 | |
| Domain | MYOSIN_MOTOR | 3.78e-03 | 38 | 45 | 2 | PS51456 | |
| Domain | Myosin_head | 3.78e-03 | 38 | 45 | 2 | PF00063 | |
| Domain | MYSc | 3.78e-03 | 38 | 45 | 2 | SM00242 | |
| Domain | VWF_dom | 4.60e-03 | 42 | 45 | 2 | IPR001007 | |
| Pathway | BIOCARTA_CIRCADIAN_PATHWAY | 9.99e-05 | 6 | 37 | 2 | M22067 | |
| Pathway | WP_MELATONIN_METABOLISM_AND_EFFECTS | 1.22e-04 | 37 | 37 | 3 | M39418 | |
| Pathway | BIOCARTA_CIRCADIAN_PATHWAY | 1.40e-04 | 7 | 37 | 2 | MM1578 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.26e-06 | 410 | 47 | 7 | 26949251 | |
| Pubmed | Delay in feedback repression by cryptochrome 1 is required for circadian clock function. | 1.79e-06 | 2 | 47 | 2 | 21236481 | |
| Pubmed | CRY1, CRY2 and PRKCDBP genetic variants in metabolic syndrome. | 1.79e-06 | 2 | 47 | 2 | 25391456 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 20825493 | ||
| Pubmed | The ratio of intracellular CRY proteins determines the clock period length. | 1.79e-06 | 2 | 47 | 2 | 26966073 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24187535 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 19211562 | ||
| Pubmed | Clock Regulation of Metabolites Reveals Coupling between Transcription and Metabolism. | 1.79e-06 | 2 | 47 | 2 | 28380384 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 29940771 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24782829 | ||
| Pubmed | Redox potential: differential roles in dCRY and mCRY1 functions. | 1.79e-06 | 2 | 47 | 2 | 11818067 | |
| Pubmed | Circadian oscillation of nucleotide excision repair in mammalian brain. | 1.79e-06 | 2 | 47 | 2 | 19164551 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 10518585 | ||
| Pubmed | Circadian intraocular pressure rhythm is generated by clock genes. | 1.79e-06 | 2 | 47 | 2 | 16936122 | |
| Pubmed | Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. | 1.79e-06 | 2 | 47 | 2 | 10217146 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 12696673 | ||
| Pubmed | Analysis of autophosphorylating kinase activities of Arabidopsis and human cryptochromes. | 1.79e-06 | 2 | 47 | 2 | 17073458 | |
| Pubmed | Mammalian cryptochromes impinge on cell cycle progression in a circadian clock-independent manner. | 1.79e-06 | 2 | 47 | 2 | 22033214 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 18614689 | ||
| Pubmed | Characterization of photolyase/blue-light receptor homologs in mouse and human cells. | 1.79e-06 | 2 | 47 | 2 | 9801304 | |
| Pubmed | Synchronization of cellular clocks in the suprachiasmatic nucleus. | 1.79e-06 | 2 | 47 | 2 | 14631044 | |
| Pubmed | Autonomic and cardiovascular responses to scent stimulation are altered in cry KO mice. | 1.79e-06 | 2 | 47 | 2 | 17175102 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 19487679 | ||
| Pubmed | Further characterization of the phenotype of mCry1/mCry2-deficient mice. | 1.79e-06 | 2 | 47 | 2 | 11587085 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 32291799 | ||
| Pubmed | CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome. | 1.79e-06 | 2 | 47 | 2 | 20453063 | |
| Pubmed | Suppression of circadian clock protein cryptochrome 2 promotes osteoarthritis. | 1.79e-06 | 2 | 47 | 2 | 32339698 | |
| Pubmed | Putative human blue-light photoreceptors hCRY1 and hCRY2 are flavoproteins. | 1.79e-06 | 2 | 47 | 2 | 8909283 | |
| Pubmed | CRY1 and CRY2 genetic variants in seasonality: A longitudinal and cross-sectional study. | 1.79e-06 | 2 | 47 | 2 | 27267441 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 17442820 | ||
| Pubmed | Circadian rhythm of RNA N6-methyladenosine and the role of cryptochrome. | 1.79e-06 | 2 | 47 | 2 | 26239657 | |
| Pubmed | Altered food-anticipatory activity rhythm in Cryptochrome-deficient mice. | 1.79e-06 | 2 | 47 | 2 | 15893577 | |
| Pubmed | Circadian behavioral rhythms in Cry1/Cry2 double-deficient mice induced by methamphetamine. | 1.79e-06 | 2 | 47 | 2 | 18258761 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24211491 | ||
| Pubmed | Mammalian clock gene Cryptochrome regulates arthritis via proinflammatory cytokine TNF-alpha. | 1.79e-06 | 2 | 47 | 2 | 20042581 | |
| Pubmed | Interval timing is intact in arrhythmic Cry1/Cry2-deficient mice. | 1.79e-06 | 2 | 47 | 2 | 21775289 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 22025708 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 18514517 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24386234 | ||
| Pubmed | Role of mouse cryptochrome blue-light photoreceptor in circadian photoresponses. | 1.79e-06 | 2 | 47 | 2 | 9822380 | |
| Pubmed | The Potorous CPD photolyase rescues a cryptochrome-deficient mammalian circadian clock. | 1.79e-06 | 2 | 47 | 2 | 21858120 | |
| Pubmed | Serine phosphorylation of mCRY1 and mCRY2 by mitogen-activated protein kinase. | 1.79e-06 | 2 | 47 | 2 | 15298678 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 34172584 | ||
| Pubmed | Cryptochrome-deficient mice lack circadian electrical activity in the suprachiasmatic nuclei. | 1.79e-06 | 2 | 47 | 2 | 12121621 | |
| Pubmed | Expression of the blue-light receptor cryptochrome in the human retina. | 1.79e-06 | 2 | 47 | 2 | 14507900 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 14712914 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24344304 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24278295 | ||
| Pubmed | High-fat diet-induced hyperinsulinemia and tissue-specific insulin resistance in Cry-deficient mice. | 1.79e-06 | 2 | 47 | 2 | 23531614 | |
| Pubmed | Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. | 1.79e-06 | 2 | 47 | 2 | 16061665 | |
| Pubmed | Daily variation in the electrophysiological activity of mouse medial habenula neurones. | 1.79e-06 | 2 | 47 | 2 | 24247982 | |
| Pubmed | Deregulated expression of cryptochrome genes in human colorectal cancer. | 1.79e-06 | 2 | 47 | 2 | 26768731 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 19278294 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 10636810 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 12483519 | ||
| Pubmed | Circadian clock cryptochrome proteins regulate autoimmunity. | 1.79e-06 | 2 | 47 | 2 | 29109286 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 22216107 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 23317246 | ||
| Pubmed | Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines. | 1.79e-06 | 2 | 47 | 2 | 22778400 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 28017587 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 12495442 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 34446572 | ||
| Pubmed | Clock gene defect disrupts light-dependency of autonomic nerve activity. | 1.79e-06 | 2 | 47 | 2 | 17964540 | |
| Pubmed | Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression. | 1.79e-06 | 2 | 47 | 2 | 19940241 | |
| Pubmed | Nuclear Proteomics Uncovers Diurnal Regulatory Landscapes in Mouse Liver. | 1.79e-06 | 2 | 47 | 2 | 27818260 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 15331384 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 23575670 | ||
| Pubmed | MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity. | 1.85e-06 | 150 | 47 | 5 | 22678362 | |
| Pubmed | 2.81e-06 | 72 | 47 | 4 | 36376293 | ||
| Pubmed | Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis. | 5.36e-06 | 3 | 47 | 2 | 21628572 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 30108144 | ||
| Pubmed | Regulation of apoptosis by the circadian clock through NF-kappaB signaling. | 5.36e-06 | 3 | 47 | 2 | 21690409 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 15860530 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 19037239 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 15010208 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 16970803 | ||
| Pubmed | Cell-autonomous clock of astrocytes drives circadian behavior in mammals. | 5.36e-06 | 3 | 47 | 2 | 30630934 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 21521686 | ||
| Pubmed | Loss of cryptochrome reduces cancer risk in p53 mutant mice. | 5.36e-06 | 3 | 47 | 2 | 19188586 | |
| Pubmed | CRY1-CBS binding regulates circadian clock function and metabolism. | 5.36e-06 | 3 | 47 | 2 | 32383312 | |
| Pubmed | Circadian and Feeding Rhythms Orchestrate the Diurnal Liver Acetylome. | 5.36e-06 | 3 | 47 | 2 | 28813682 | |
| Pubmed | A circadian clock regulates efflux by the blood-brain barrier in mice and human cells. | 5.36e-06 | 3 | 47 | 2 | 33504784 | |
| Pubmed | Circadian clock genes directly regulate expression of the Na(+)/H(+) exchanger NHE3 in the kidney. | 5.36e-06 | 3 | 47 | 2 | 15780093 | |
| Pubmed | Cryptochrome-dependent circadian periods in the arcuate nucleus. | 5.36e-06 | 3 | 47 | 2 | 26542738 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 11889036 | ||
| Pubmed | Loss of circadian rhythmicity in aging mPer1-/-mCry2-/- mutant mice. | 5.36e-06 | 3 | 47 | 2 | 12782655 | |
| Pubmed | Genome-wide expression analysis of mouse liver reveals CLOCK-regulated circadian output genes. | 5.36e-06 | 3 | 47 | 2 | 12865428 | |
| Pubmed | DNA damage-specific control of cell death by cryptochrome in p53-mutant ras-transformed cells. | 5.36e-06 | 3 | 47 | 2 | 23149912 | |
| Pubmed | Differential roles for cryptochromes in the mammalian retinal clock. | 5.36e-06 | 3 | 47 | 2 | 29561690 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 36866044 | ||
| Pubmed | Intrinsic and extrinsic cues regulate the daily profile of mouse lateral habenula neuronal activity. | 5.36e-06 | 3 | 47 | 2 | 25194046 | |
| Pubmed | Circadian regulation of food-anticipatory activity in molecular clock-deficient mice. | 5.36e-06 | 3 | 47 | 2 | 23145013 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 30487216 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 22549838 | ||
| Pubmed | Effect of vitamin A depletion on nonvisual phototransduction pathways in cryptochromeless mice. | 5.36e-06 | 3 | 47 | 2 | 15523112 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 25707907 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 21193487 | ||
| Pubmed | Suprachiasmatic nucleus grafts restore circadian behavioral rhythms of genetically arrhythmic mice. | 5.36e-06 | 3 | 47 | 2 | 12699623 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 26930624 | ||
| Pubmed | Association between AVPR1A, DRD2, and ASPM and endophenotypes of communication disorders. | 5.36e-06 | 3 | 47 | 2 | 24849541 | |
| Interaction | MKI67 interactions | 1.09e-05 | 648 | 45 | 9 | int:MKI67 | |
| Interaction | DNAJC7 interactions | 4.01e-05 | 425 | 45 | 7 | int:DNAJC7 | |
| Interaction | PTGES3 interactions | 4.78e-05 | 437 | 45 | 7 | int:PTGES3 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.71e-03 | 53 | 31 | 2 | 532 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_24H_BMDC_UP | 2.55e-05 | 199 | 46 | 5 | M3723 | |
| Coexpression | GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_UP | 2.55e-05 | 199 | 46 | 5 | M9220 | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 1.41e-06 | 183 | 47 | 5 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.41e-06 | 183 | 47 | 5 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-06 | 119 | 47 | 4 | c3f1223356e7f245a460ea5568a223e34e458dc1 | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 9.53e-06 | 126 | 47 | 4 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.95e-05 | 168 | 47 | 4 | c34dd4a9c54d8e9c8f118e6a3816548890cb0746 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma-6|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.31e-05 | 173 | 47 | 4 | 7714d27e53b02af4e071154cf2ea001fab347235 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.62e-05 | 177 | 47 | 4 | 3e149bff1f1b393a7abe98984e37981c8296f95d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 179 | 47 | 4 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.87e-05 | 62 | 47 | 3 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.87e-05 | 62 | 47 | 3 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | wk_08-11-Hematologic-Myeloid-pre-pDC/DC5|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.03e-05 | 182 | 47 | 4 | fec8a2d6d4099722b8e1bb41222108ed74268fcf | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 4.30e-05 | 185 | 47 | 4 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.77e-05 | 190 | 47 | 4 | b69940d16685249167d4c2cf6ad8237ccf6f7590 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.77e-05 | 190 | 47 | 4 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Control-Lymphoid-CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 5.27e-05 | 195 | 47 | 4 | 8679a122fe796b1eddef82460e985b3fd3b3a2a5 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.49e-05 | 197 | 47 | 4 | 76b61e60a757e58b465569538e632d6d9953e89a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.82e-05 | 200 | 47 | 4 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.82e-05 | 200 | 47 | 4 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.82e-05 | 200 | 47 | 4 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| Disease | Mental Depression | 4.19e-05 | 254 | 45 | 5 | C0011570 | |
| Disease | COVID-19, obesity | 4.75e-05 | 7 | 45 | 2 | EFO_0001073, MONDO_0100096 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 4.75e-05 | 7 | 45 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Depressive disorder | 7.72e-05 | 289 | 45 | 5 | C0011581 | |
| Disease | aggressive behaviour measurement, ADHD symptom measurement | 1.55e-04 | 68 | 45 | 3 | EFO_0007826, EFO_0007860 | |
| Disease | Seasonal Affective Disorder | 2.69e-04 | 16 | 45 | 2 | C0085159 | |
| Disease | coagulation factor measurement | 4.25e-04 | 20 | 45 | 2 | EFO_0004634 | |
| Disease | brain ischemia (biomarker_via_orthology) | 5.12e-04 | 102 | 45 | 3 | DOID:2316 (biomarker_via_orthology) | |
| Disease | Myeloid Leukemia, Chronic | 8.99e-04 | 29 | 45 | 2 | C0023473 | |
| Disease | Astigmatism | 1.01e-03 | 129 | 45 | 3 | HP_0000483 | |
| Disease | Hyperkinesia, Generalized | 1.10e-03 | 32 | 45 | 2 | C0751217 | |
| Disease | Hyperkinesia | 1.10e-03 | 32 | 45 | 2 | C3887506 | |
| Disease | internet addiction disorder | 1.17e-03 | 33 | 45 | 2 | EFO_0803368 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LIVRYQRMNGRYNFK | 1291 | Q5DID0 | |
| NGRRIYYGMNALRAK | 751 | Q15361 | |
| QRYFLGQRRKSEVVM | 171 | P40145 | |
| RLVTAYQRSYKREQM | 1751 | Q9HCK8 | |
| RYRTMGNVARRKYAA | 251 | Q5FYB1 | |
| TKKNRSLYRNILMYG | 386 | Q9NVI7 | |
| HLYRTQYLKGVNRSM | 306 | A6NFU0 | |
| FKQRSRMYGATVIVR | 241 | Q9H694 | |
| LITAYQRSYKRQQMR | 1916 | Q9P2D1 | |
| QAFVRGYLVRKQMRL | 1736 | Q8IZT6 | |
| IQVRCRAYYQGKMQR | 2146 | Q8IZT6 | |
| RRYLYVRLDGTMSIK | 536 | Q92698 | |
| QRYRSGIRGYMKTVV | 1116 | O00763 | |
| YIQRSRRLYGNTPMR | 946 | Q14667 | |
| LYVRRQTARMRLSKY | 1446 | Q4ZG55 | |
| VLSQKRMYRKYHQRP | 56 | O75369 | |
| MLVYSGYSKETLRQR | 1626 | O00443 | |
| QIVQALRYDKMGYVR | 1656 | P42356 | |
| YRKVNRVLPRSNMVY | 1381 | Q07864 | |
| SKMTQRRGYLLLYGT | 141 | Q96P66 | |
| VYRAVMRNTVYAVKR | 226 | P51617 | |
| RRLYRSMNSQYLKLL | 371 | P10619 | |
| KYRRLRIMTNIYLLN | 61 | P51677 | |
| ERMKQIYQQLSRYRG | 501 | Q49AN0 | |
| IERMKQIYQQLSRYR | 481 | Q16526 | |
| RMKRIFYRIGNKGIY | 136 | Q9NPH9 | |
| RRYSLPLKSIYMRQI | 636 | Q92611 | |
| LYNTRYSSKRRVTVM | 141 | P14416 | |
| IMNQVSNAYLYRKRI | 206 | O14569 | |
| TRKYTRQILEGMSYL | 466 | Q99759 | |
| MYIKQVIIQGFRSYR | 1 | Q9UQE7 | |
| QRYLTRKIGFEAVMR | 736 | O95486 | |
| RLYQQTLRSAGKIYM | 376 | Q14524 | |
| YMTKYERARVLGTRA | 56 | P61218 | |
| RMTYQKLARALRNYA | 221 | Q01892 | |
| MSQGVLATVKRYYRA | 326 | Q4W5G0 | |
| YIRTMYLGIQSQRRK | 256 | Q5GH73 | |
| GRASRQLQRMFKAIY | 336 | Q86Y38 | |
| QRMSRNFVRYVQGLK | 1391 | P04275 | |
| KRYGGQRIRMYLSVL | 126 | A0PJK1 | |
| RLRQQLEMYSISRKY | 76 | Q96E16 | |
| RGRYVNQMIINYVKR | 96 | Q9NQX6 | |
| YDTYGSTRKNLRMIL | 86 | A0A0C4DH28 | |
| LMRYYKQRFGLSRAV | 396 | Q969S3 | |
| GRGLYVYSLQMKRVI | 301 | Q9HAD4 | |
| RYKDQTGGYTRMLQI | 96 | Q9NRX2 | |
| SYRLQGRMTYVLIKT | 2346 | Q9Y493 | |
| MRNLQLRFEKGRIYT | 26 | B0I1T2 | |
| KAAITMQRYVRGYQA | 791 | Q9Y4I1 |